Novel mutations contribute to progression of venetoclax-treated CLLFebruary 2, 2020Leukemia, Myelodysplasia, Transplantation
ECHELON-1 update: A+AVD bests ABVD in Hodgkin lymphomaFebruary 1, 2020Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapyJanuary 22, 2020ALLTransplantation
Ofatumumab works safely for elderly patients with CLL, comorbiditiesJanuary 22, 2020Leukemia, Myelodysplasia, Transplantation
Start of myeloma therapy may be delayed for women, minoritiesJanuary 21, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Sevuparin failed for acute VOC in sickle cell, but may have preventive potentialJanuary 21, 2020Anemia
CAR T-cell therapy may worsen mental health in some patientsJanuary 21, 2020TransplantationLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Are providers asking about menstrual bleeding before/during anticoagulant therapy?January 16, 2020Thrombosis
Promising early efficacy of venetoclax/navitoclax in r/r acute lymphoblastic leukemiaJanuary 15, 2020ALLLeukemia, Myelodysplasia, TransplantationPediatrics
REGN1979 shows good activity in pretreated aggressive B-NHLJanuary 15, 2020DLBCLLymphoma & Plasma Cell Disorders
Chemo-free induction-consolidation protocol for Ph+ ALL improved survivalJanuary 14, 2020ALLLeukemia, Myelodysplasia, Transplantation
